Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06328387
What this trial is testing

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Who this might be right for
Advanced Breast CancerMetastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)UnknownNCT00499525
What this trial is testing

Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University 180
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Not applicableNot Yet RecruitingNCT05980208
What this trial is testing

A Real-world Study of Inetetamab for First-line Treatment of MBC

Who this might be right for
Breast CancerReal-world Study
Hunan Cancer Hospital 150
Early research (Phase 1)Ended earlyNCT06878248
What this trial is testing

Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast+3 more
Calibr, a division of Scripps Research 10
Not applicableEnded earlyNCT04396626
What this trial is testing

HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

Who this might be right for
Breast Cancer
Pfizer 975
Early research (Phase 1)Study completedNCT03251378
What this trial is testing

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers

Who this might be right for
Advanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more
Hutchison Medipharma Limited 129
Large-scale testing (Phase 3)Study completedNCT03262935
What this trial is testing

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Byondis B.V. 437
Large-scale testing (Phase 3)Study completedNCT05054751
What this trial is testing

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Genor Biopharma Co., Ltd. 275
Testing effectiveness (Phase 2)UnknownNCT02144194
What this trial is testing

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

Who this might be right for
Breast Cancer
Cancer Research Group - Collaborative Group, Beirut, Lebanon. 65
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00313170
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

Who this might be right for
Advanced Breast CancerMetastatic Breast Cancer
AstraZeneca 144
Early research (Phase 1)Study completedNCT02719691
What this trial is testing

Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerSolid Tumors
University of Colorado, Denver 47
Testing effectiveness (Phase 2)Study completedNCT00376688
What this trial is testing

Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)Study completedNCT00868634
What this trial is testing

Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
iOMEDICO AG 600
Early research (Phase 1)WithdrawnNCT00074139
What this trial is testing

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT01935492
What this trial is testing

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastMetastatic Breast Cancer
Borstkanker Onderzoek Groep 420
Testing effectiveness (Phase 2)Study completedNCT04699630
What this trial is testing

U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
SCRI Development Innovations, LLC 121
Large-scale testing (Phase 3)UnknownNCT05861830
What this trial is testing

Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)

Who this might be right for
Advanced Breast Cancer
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00003428
What this trial is testing

Hormone Therapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 114
Next Page